banner

The official advocacy organization for pharmacist women in the United States

Advertisement

Pharmacist Moms Group

45,000+ Members

45,000+ Members

Over 6 Million posts, comments and reactions in 2020

Over 6 Million posts, comments and reactions in 2020

60,000+ Followers on social media platforms

60,000+ Followers on social media platforms

The Largest Community of Women Pharmacists in the US

pharmacist moms

Founded in 2017, Pharmacists Moms Group was created to provide women pharmacists the opportunity to network, collaborate and offer genuine feedback in a closed-door, trusted setting. The organization has quickly grown to over 45,000 members and 60,000 followers on our social media platforms.

Pharmacy News
View More
Brain Inflammation May Not Drive Persistent Long COVID Symptoms, New Imaging Study Finds

PET scans show long COVID mood and brain fog link to limbic activity, not widespread brain inflammation, reshaping COVID-19 treatment targets.

Elranatamab Demonstrates High Response Rates and Manageable Safety in High-Risk Smoldering Multiple Myeloma

Elranatamab monotherapy produced a 92% overall response rate and a 45% complete response rate in patients with high-risk smoldering multiple myeloma, supporting the potential of BCMA-directed bispecific antibody therapy as an early intervention strategy before progression to active disease.

Closing the Knowledge Gap: What Community Pharmacists Need to Know About Menopause

Discover how community pharmacists can spot menopause beyond hot flashes, avoid HRT mix-up myths, and collaborate on safe, updated treatments.

Beyond Hot Flashes: How Our Understanding of Menopause and VMS Has Evolved

Learn how menopause VMS stem from the brain, last years, affect heart risk, and when hormone therapy is considered safe.

Subcutaneous Isatuximab On-Body Injector Shows High Reliability, Favorable Safety Across Multiple Myeloma Trials

Cross-trial data from more than 6000 administrations show that a subcutaneous isatuximab on-body injector was highly reliable and well tolerated.

Real-World Use of Talazoparib Plus Enzalutamide and HR Testing Trends in Prostate Cancer

Real-world adoption of talazoparib plus enzalutamide in metastatic castration-resistant prostate cancer highlights ongoing gaps in homologous recombination (HR) biomarker testing across prostate cancer care.

Advertisement
Advertisement

Official Media Partner

Official Media Partner

Official CE Partner

Official CE Partner

Founder of Women Pharmacist Day

Founder of Women Pharmacist Day
pharmacist moms group logo
Stay In Touch
an mjh life sciences brand

© 2021 MJH Life Sciences and Pharmacy Times®. All rights reserved.

Privacy Policy